{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06104124",
            "orgStudyIdInfo": {
                "id": "HZNP-DAZ-301"
            },
            "secondaryIdInfos": [
                {
                    "id": "2023-503904-10-00",
                    "type": "REGISTRY",
                    "domain": "EU Clinical Trial Information System"
                }
            ],
            "organization": {
                "fullName": "Amgen",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sj\u00f6gren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity",
            "officialTitle": "A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sj\u00f6gren's Syndrome With Moderate-to-severe Systemic Disease Activity",
            "therapeuticArea": [
                "Rare Diseases"
            ],
            "study": "a-study-to-evaluate-the-efficacy-and-safety-of-dazodalibep-in-participants-with-s-syndrome-ss-with-moderate-to-severe-systemic-disease-activity"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-10-26",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-07-28",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-07-28",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-10-23",
            "studyFirstSubmitQcDate": "2023-10-23",
            "studyFirstPostDateStruct": {
                "date": "2023-10-27",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-29",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-30",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Amgen",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Primary Objective:\n\nTo evaluate the effect of dazodalibep on systemic manifestations of Sj\u00f6gren's Syndrome (SS) in participants with moderate-to-severe systemic disease activity.\n\nSecondary Objectives:\n\n1. To evaluate the effect of dazodalibep on patient reported outcomes (PROs) in participants with SS.\n2. To evaluate the safety and tolerability of dazodalibep in participants with SS",
            "detailedDescription": "Acquired from Horizon in 2024."
        },
        "conditionsModule": {
            "conditions": [
                "Sjogren's Syndrome"
            ],
            "keywords": [
                "Sj\u00f6gren's Syndrome With Moderate-to-severe Systemic Disease Activity Study Phase: Phase 3",
                "European Alliance of Associations for Rheumatology Sj\u00f6gren's Syndrome Disease Activity Index (ESSDAI)",
                "European Alliance of Associations for Rheumatology Sj\u00f6gren's Syndrome Patient Reported Index (ESSPRI)",
                "European Alliance of Associations for Rheumatology (EULAR)"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 510,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Dazodalibep Dose 1",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will be administered dose 1 of dazodalibep by intravenous (IV) infusion.",
                    "interventionNames": [
                        "Drug: Dazodalibep"
                    ]
                },
                {
                    "label": "Dazodalibep Dose 2",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will be administered dose 2 of dazodalibep by IV infusion.",
                    "interventionNames": [
                        "Drug: Dazodalibep"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Participants will be administered placebo by IV infusion.",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Dazodalibep",
                    "description": "IV infusion",
                    "armGroupLabels": [
                        "Dazodalibep Dose 1",
                        "Dazodalibep Dose 2"
                    ],
                    "otherNames": [
                        "VIB 4920",
                        "MEDI 4920"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "IV infusion",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change from baseline in European Alliance of Associations for Rheumatology Sj\u00f6gren's Syndrome Disease Activity Index (ESSDAI) Score",
                    "timeFrame": "At Week 48"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Proportion of participants achieving ESSDAI response",
                    "timeFrame": "At Week 48"
                },
                {
                    "measure": "Change from baseline in Diary for Assessing Sjogren's Patient-Reported Outcome Index (DASPRI) dryness domain score",
                    "timeFrame": "At Week 48"
                },
                {
                    "measure": "Change from baseline in ESSPRI dryness domain score",
                    "timeFrame": "At Week 48"
                },
                {
                    "measure": "Change from baseline in tender and swollen joint counts",
                    "timeFrame": "At Week 48"
                },
                {
                    "measure": "Change from baseline in Patient-Reported Outcomes Measurement Information System Fatigue-Short Form 10a (PROMIS-Fatigue-SF-10a)",
                    "timeFrame": "At Week 48"
                },
                {
                    "measure": "Change from baseline in ESSDAI score",
                    "timeFrame": "Week 12 and Week 24"
                },
                {
                    "measure": "Change from baseline in DASPRI total score",
                    "timeFrame": "At Week 48"
                },
                {
                    "measure": "Change from baseline in ESSPRI total score",
                    "timeFrame": "At Week 48"
                },
                {
                    "measure": "Change from baseline in total stimulated salivary flow",
                    "timeFrame": "At Week 48"
                },
                {
                    "measure": "Number of participants With Treatment Emergent Adverse Events (TEAEs)",
                    "timeFrame": "Baseline (Day 1) to Week 56"
                },
                {
                    "measure": "Number of participants With Treatment Emergent Serious Adverse Events (TESAEs)",
                    "timeFrame": "Up to Week 56"
                },
                {
                    "measure": "Number of participants With Adverse Events of Special Interest (AESIs)",
                    "timeFrame": "Up to Week 56"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Diagnosed with Sj\u00f6gren's syndrome (SS) by meeting the 2016 American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology (EULAR) Classification Criteria.\n* Have an European Alliance of Associations for Rheumatology Sj\u00f6gren's Syndrome Disease Activity Index (ESSDAI) score of \\>= 5 despite symptomatic or local therapy at screening.\n* Positive for either anti-Ro autoantibodies or rheumatoid factor (RF), or both at screening (as per the central laboratory test).\n\nKey Exclusion Criteria:\n\n* Medical history of confirmed deep vein thrombosis, pulmonary embolism, or arterial thromboembolism within 2 years of screening.\n* Active malignancy or history of malignancy within the last 5 years, except in situ carcinoma of cervix treated with apparent success with curative therapy \\> 12 months prior to screening OR cutaneous basal cell carcinoma following presumed curative therapy.\n* Individuals with any severe or life-threatening cardiovascular (including vasculitis), respiratory, endocrine, gastrointestinal, hematological, psychiatric, or systemic disorder or any other condition that would place the individual at unacceptable risk of complications, interfere with evaluation of the IP, or confound the interpretation of participant safety or study results.\n* Individuals who have a positive test for, or have been treated for, hepatitis B, hepatitis C (unless they have undergone hepatitis C antiviral treatment and have undetectable viral level of hepatitis C RNA at least 24 weeks following completion of therapy) or human immunodeficiency virus (HIV) infection.\n* Active TB or untreated (per local guidelines) latent TB\n* Individuals with a history of more than one episode of herpes zoster and/or any opportunistic infection in the last 12 months, and active infection requiring systemic treatment at the time of screening or through randomization, or history of more than 2 infections requiring intravenous (IV) antibiotics within 12 months prior to screening.\n* Individuals who have received a live (attenuated) vaccine within the 4 weeks prior to randomization or plan to receive a live vaccine during their participation in the study.\n* Last administration of experimental or investigational biologic or oral agents \\< 6 months prior to screening.\n* Individuals who have had previous treatment with any biologic B-cell-depleting therapy (eg, rituximab, ocrelizumab, inebilizumab, ofatumumab, or ianalumab) within 12 months or other B-cell-targeting therapy (eg, belimumab) \\< 3 months prior to screening.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Amgen Call Center",
                    "role": "CONTACT",
                    "phone": "866-572-6436",
                    "email": "medinfo@amgen.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "MD",
                    "affiliation": "Amgen",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Arizona Research Clinic PLLC",
                    "status": "RECRUITING",
                    "city": "Chandler",
                    "state": "Arizona",
                    "zip": "85225-2915",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.30616,
                        "lon": -111.84125
                    }
                },
                {
                    "facility": "Arizona Arthritis and Rheumatology Associates - Flagstaff - 399 S Malpais Ln",
                    "status": "RECRUITING",
                    "city": "Flagstaff",
                    "state": "Arizona",
                    "zip": "86001-6299",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.19807,
                        "lon": -111.65127
                    }
                },
                {
                    "facility": "Arizona Arthritis and Rheumatology Associates - Glendale - 5681 W Beverly Ln",
                    "status": "RECRUITING",
                    "city": "Glendale",
                    "state": "Arizona",
                    "zip": "85306-9800",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.53865,
                        "lon": -112.18599
                    }
                },
                {
                    "facility": "Arizona Arthritis and Rheumatology Associates - Tucson - 2001 W Orange Grove Rd",
                    "status": "RECRUITING",
                    "city": "Tucson",
                    "state": "Arizona",
                    "zip": "85704-1140",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.22174,
                        "lon": -110.92648
                    }
                },
                {
                    "facility": "Wallace Rheumatic Studies Center, LLC",
                    "status": "RECRUITING",
                    "city": "Beverly Hills",
                    "state": "California",
                    "zip": "90211-2703",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.07362,
                        "lon": -118.40036
                    }
                },
                {
                    "facility": "Inland Rheumatology Clinical Trials Incorporated",
                    "status": "RECRUITING",
                    "city": "Upland",
                    "state": "California",
                    "zip": "91786-4951",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.09751,
                        "lon": -117.64839
                    }
                },
                {
                    "facility": "Tekton Research, LLC - Fort Collins - PPDS",
                    "status": "RECRUITING",
                    "city": "Fort Collins",
                    "state": "Colorado",
                    "zip": "80528-3404",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.58526,
                        "lon": -105.08442
                    }
                },
                {
                    "facility": "Bradenton Research Center Inc",
                    "status": "RECRUITING",
                    "city": "Bradenton",
                    "state": "Florida",
                    "zip": "34205-1704",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.49893,
                        "lon": -82.57482
                    }
                },
                {
                    "facility": "Clinical Research of West Florida Inc - Clearwater",
                    "status": "RECRUITING",
                    "city": "Clearwater",
                    "state": "Florida",
                    "zip": "33765-2616",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.96585,
                        "lon": -82.8001
                    }
                },
                {
                    "facility": "West Broward Rheumatology Associates, Inc.",
                    "status": "RECRUITING",
                    "city": "Tamarac",
                    "state": "Florida",
                    "zip": "33321-2956",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 26.21286,
                        "lon": -80.24977
                    }
                },
                {
                    "facility": "Tufts Medical Center - Rheumatology Research Office - PPDS",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02111-1527",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Shores Rheumatology",
                    "status": "RECRUITING",
                    "city": "Saint Clair Shores",
                    "state": "Michigan",
                    "zip": "48081-1274",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.49698,
                        "lon": -82.88881
                    }
                },
                {
                    "facility": "Amarillo Center For Clinical Research - ClinEdge - PPDS",
                    "status": "RECRUITING",
                    "city": "Amarillo",
                    "state": "Texas",
                    "zip": "79124-1601",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.222,
                        "lon": -101.8313
                    }
                },
                {
                    "facility": "Accurate Clinical Management - Baytown",
                    "status": "RECRUITING",
                    "city": "Baytown",
                    "state": "Texas",
                    "zip": "77521-2279",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.7355,
                        "lon": -94.97743
                    }
                },
                {
                    "facility": "Precision Comprehensive Clinical Research Solutions",
                    "status": "RECRUITING",
                    "city": "Grapevine",
                    "state": "Texas",
                    "zip": "76051-3143",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.93429,
                        "lon": -97.07807
                    }
                },
                {
                    "facility": "R & H Clinical Research-Katy-777 S Fry Rd",
                    "status": "RECRUITING",
                    "city": "Katy",
                    "state": "Texas",
                    "zip": "77450",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.78579,
                        "lon": -95.8244
                    }
                },
                {
                    "facility": "Valley Arthritis Center",
                    "status": "RECRUITING",
                    "city": "McAllen",
                    "state": "Texas",
                    "zip": "78501",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 26.20341,
                        "lon": -98.23001
                    }
                },
                {
                    "facility": "Consultorios M\u00e9dicos Dr. Doreski - PPDS",
                    "status": "RECRUITING",
                    "city": "Ciudad Aut\u00f3noma de Buenos Aires",
                    "state": "Buenos Aires",
                    "zip": "C1426ABP",
                    "country": "Argentina",
                    "geoPoint": {
                        "lat": -34.61315,
                        "lon": -58.37723
                    }
                },
                {
                    "facility": "Instituto de Investigaciones Clinicas Quilmes SRL",
                    "status": "RECRUITING",
                    "city": "Quilmes",
                    "state": "Buenos Aires",
                    "zip": "B1878GEG",
                    "country": "Argentina",
                    "geoPoint": {
                        "lat": -34.72904,
                        "lon": -58.26374
                    }
                },
                {
                    "facility": "Centro de Investigaciones M\u00e9dicas Tucum\u00e1n - PPDS",
                    "status": "RECRUITING",
                    "city": "San Miguel De Tucum\u00e1n",
                    "state": "Tucum\u00e1n",
                    "zip": "T4000AXL",
                    "country": "Argentina",
                    "geoPoint": {
                        "lat": -26.82414,
                        "lon": -65.2226
                    }
                },
                {
                    "facility": "Japan Community Health Care Organization (JCHO) Chukyo Hospital",
                    "status": "RECRUITING",
                    "city": "Nagoya-Shi",
                    "state": "Aiti",
                    "zip": "457-0866",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.18147,
                        "lon": 136.90641
                    }
                },
                {
                    "facility": "Sasebo Chuo Hospital",
                    "status": "RECRUITING",
                    "city": "Sasebo-Shi",
                    "state": "Nagasaki",
                    "zip": "857-1165",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 33.16832,
                        "lon": 129.72501
                    }
                },
                {
                    "facility": "Hamamatsu University Hospital",
                    "status": "RECRUITING",
                    "city": "Hamamatsu-city",
                    "state": "Sizuoka",
                    "zip": "431-3192",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 34.7,
                        "lon": 137.73333
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "AmgenTrials clinical trials website",
                    "url": "http://www.amgentrials.com"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "De-identified individual patient data for variables necessary to address the specific research question in an approved data sharing request.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "ICF",
                "CSR"
            ],
            "timeFrame": "Data sharing requests relating to this study will be considered beginning 18 months after the study has ended and either 1) the product and indication have been granted marketing authorization in both the US and Europe or 2) clinical development for the product and/or indication discontinues and the data will not be submitted to regulatory authorities. There is no end date for eligibility to submit a data sharing request for this study.",
            "accessCriteria": "Qualified researchers may submit a request containing the research objectives, the Amgen product(s) and Amgen study/studies in scope, endpoints/outcomes of interest, statistical analysis plan, data requirements, publication plan, and qualifications of the researcher(s). In general, Amgen does not grant external requests for individual patient data for the purpose of re-evaluating safety and efficacy issues already addressed in the product labelling. Requests are reviewed by a committee of internal advisors. If not approved, a Data Sharing Independent Review Panel will arbitrate and make the final decision. Upon approval, information necessary to address the research question will be provided under the terms of a data sharing agreement. This may include anonymized individual patient data and/or available supporting documents, containing fragments of analysis code where provided in analysis specifications. Further details are available at the URL below.",
            "url": "http://www.amgen.com/datasharing"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30",
            "removedCountries": [
                "Canada",
                "Chile",
                "Israel",
                "Korea, Republic of"
            ]
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000012859",
                    "term": "Sjogren's Syndrome"
                },
                {
                    "id": "D000013577",
                    "term": "Syndrome"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004194",
                    "term": "Disease"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000001172",
                    "term": "Arthritis, Rheumatoid"
                },
                {
                    "id": "D000001168",
                    "term": "Arthritis"
                },
                {
                    "id": "D000007592",
                    "term": "Joint Diseases"
                },
                {
                    "id": "D000009140",
                    "term": "Musculoskeletal Diseases"
                },
                {
                    "id": "D000012216",
                    "term": "Rheumatic Diseases"
                },
                {
                    "id": "D000014987",
                    "term": "Xerostomia"
                },
                {
                    "id": "D000012466",
                    "term": "Salivary Gland Diseases"
                },
                {
                    "id": "D000009059",
                    "term": "Mouth Diseases"
                },
                {
                    "id": "D000009057",
                    "term": "Stomatognathic Diseases"
                },
                {
                    "id": "D000015352",
                    "term": "Dry Eye Syndromes"
                },
                {
                    "id": "D000007766",
                    "term": "Lacrimal Apparatus Diseases"
                },
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                },
                {
                    "id": "D000003240",
                    "term": "Connective Tissue Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "asFound": "Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15664",
                    "name": "Sjogren's Syndrome",
                    "asFound": "Sjogren's Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4476",
                    "name": "Arthritis",
                    "relevance": "LOW"
                },
                {
                    "id": "M4480",
                    "name": "Arthritis, Rheumatoid",
                    "relevance": "LOW"
                },
                {
                    "id": "M10621",
                    "name": "Joint Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12097",
                    "name": "Musculoskeletal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15045",
                    "name": "Rheumatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6323",
                    "name": "Collagen Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17724",
                    "name": "Xerostomia",
                    "relevance": "LOW"
                },
                {
                    "id": "M15285",
                    "name": "Salivary Gland Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12019",
                    "name": "Mouth Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12017",
                    "name": "Stomatognathic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M18040",
                    "name": "Dry Eye Syndromes",
                    "relevance": "LOW"
                },
                {
                    "id": "M10664",
                    "name": "Keratoconjunctivitis Sicca",
                    "relevance": "LOW"
                },
                {
                    "id": "M10786",
                    "name": "Lacrimal Apparatus Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6464",
                    "name": "Connective Tissue Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC05",
                    "name": "Musculoskeletal Diseases"
                },
                {
                    "abbrev": "BC07",
                    "name": "Mouth and Tooth Diseases"
                },
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                }
            ]
        }
    },
    "hasResults": false
}